DEL BOCCIO, PIERO
 Distribuzione geografica
Continente #
EU - Europa 3.526
NA - Nord America 3.519
AS - Asia 1.803
SA - Sud America 116
OC - Oceania 13
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 8.994
Nazione #
US - Stati Uniti d'America 3.484
IT - Italia 1.014
SG - Singapore 780
IE - Irlanda 604
CN - Cina 541
SE - Svezia 367
UA - Ucraina 345
GB - Regno Unito 306
DE - Germania 298
TR - Turchia 281
FR - Francia 182
FI - Finlandia 150
IN - India 102
BR - Brasile 100
RU - Federazione Russa 89
NL - Olanda 35
CZ - Repubblica Ceca 34
HK - Hong Kong 31
BE - Belgio 24
CA - Canada 24
PL - Polonia 22
VN - Vietnam 22
AT - Austria 19
AU - Australia 12
AE - Emirati Arabi Uniti 10
JP - Giappone 10
LT - Lituania 9
ES - Italia 8
MX - Messico 8
AR - Argentina 5
ZA - Sudafrica 5
EU - Europa 4
KR - Corea 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CL - Cile 3
DK - Danimarca 3
GR - Grecia 3
IR - Iran 3
PK - Pakistan 3
AM - Armenia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
ID - Indonesia 2
IL - Israele 2
IQ - Iraq 2
KE - Kenya 2
UZ - Uzbekistan 2
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 8.994
Città #
Chandler 672
Dublin 596
Singapore 562
Jacksonville 426
Chieti 233
Southend 216
Princeton 199
The Dalles 159
Pescara 158
Izmir 153
Ashburn 143
Nanjing 143
Santa Clara 139
Dearborn 138
Munich 134
Ann Arbor 89
Beijing 89
Altamura 88
Wilmington 88
Boardman 76
Helsinki 68
New York 67
Cambridge 64
Rome 60
Nanchang 57
Woodbridge 43
Los Angeles 42
Hong Kong 29
Kunming 27
Shenyang 24
Brussels 23
Brno 22
Dong Ket 22
Hangzhou 19
Hebei 18
San Mateo 18
Tianjin 18
Seattle 17
Washington 17
Guangzhou 16
Nuremberg 16
Jiaxing 15
Kraków 15
Augusta 14
Frankfurt am Main 13
L'aquila 13
Lappeenranta 13
São Paulo 13
Amsterdam 12
Düsseldorf 12
London 12
Vienna 12
Grevenbroich 11
Milan 11
Norwalk 11
Teramo 11
Jinan 10
Olomouc 10
Tokyo 10
Camerino 9
Redwood City 9
Toronto 9
Bologna 8
Changsha 8
Pune 8
Sydney 8
Falls Church 7
Leawood 7
Roseto Degli Abruzzi 7
Ancona 6
Auburn Hills 6
Houston 6
L’Aquila 6
Naples 6
Shanghai 6
Turku 6
Bangalore 5
Belo Horizonte 5
Brooklyn 5
Dubai 5
Edinburgh 5
Hanover 5
La Spezia 5
Montreal 5
Ottawa 5
Padova 5
San Vito Chietino 5
Verona 5
West Jordan 5
Zhengzhou 5
Aquila 4
Brescia 4
Chicago 4
Council Bluffs 4
Lanzhou 4
Moscow 4
Orange 4
Pianella 4
Ribeirão Preto 4
Romola 4
Totale 5.638
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 290
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 154
Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis 137
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 135
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 134
Serum Lipidomic study reveals potential early biomarkers for predicting response to chemoradiotherapy in advanced rectal cancer: A pilot study 130
A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes 123
A lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosis. 121
Visible Photostability of Ruthenium and Platinum Phthalocyanines in Water and in the presence of Organic Substrates 118
Proteomic profiling of coronary thrombus in acute myocardial infarction 118
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 117
Advances in Lipidomics for Cancer Biomarkers Discovery 116
Extracellular vesicles and their potential use in monitoring cancer progression and therapy: The contribution of proteomics 115
Cleavage of cystatin C is not associated with multiple sclerosis 115
Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action 113
Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage 112
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 108
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 108
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 108
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 107
Proteomics characterization of protein adsorption onto hemodialysis membranes 106
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 105
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 105
Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry 104
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 103
Neurodegenerative diseases as proteinopathies-driven immune disorders 103
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 101
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 100
AFFINITY AND SPECIFICITY OF ANTI-GM1 ANTIBODIES IN THE EXPERIMENTAL AXONAL MODEL OF GUILLAIN-BARRE SYNDROME 100
A proteomic approach for the characterization of C677T mutation of the human gene methylenetetrahydrofolate reductase. 99
LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise 99
ESI-MS in the study of the activity of alpha-chymotrypsin in aqueous surfactant media. 98
Proteomics of thyroid fine-needle apiration: a promising approach for protein biomarker discovery 98
An Italian Innovative Small-Scale Approach to Promote the Conscious Consumption of Healthy Food 97
Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature. 96
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 96
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 96
Protein expression profiling of Proteus mirabilis under chemical stress condition: A proteomic investigation without genome 94
Stereoselective double reduction of 3-methyl-2-cyclohexenone by use of palladium and platinum nanoparticles in tandem with alcohol dehydrogenase 94
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 90
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 89
Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin. 89
Liquid chromatography-tandem mass spectrometry analysis of oleuropein and its metabolite hydroxytyrosol in rat plasma and urine after oral administration. 88
Glutathione transferases from Anguilla anguilla liver: identification, cloning and functional characterization. 87
Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence 86
extracellular vescicles as signaling mediators and disease biomarkers across biological barriers 86
Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. 85
Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma 84
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 84
Characterization of oxidation end product of plasma albumin 'in vivo'. 84
Pre-analytical factors in clinical proteomics investigations: Impact of ex vivo protein modifications for multiple sclerosis biomarker discovery 84
Homo sapiens proteomics: clinical perspectives 83
Transitions of serum albumin in patients with glomerulosclerosis 'in vivo' characterization by electrophoretic titration curves. 83
Proteomic investigation in the detection of the illicit treatment of calves with growth-promoting agents. 83
Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells. 83
Lo sviluppo di un confronto matematico per analisi differenziali di proteomica: applicazione ai profili MALDI-TOF-MS lineare. 83
Quantitative analysis of caffeic acid phenethyl ester in crude propolis by liquid chromatography-electrospray ionization mass spectrometry. 82
Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy. 82
Cytotoxic and genotoxic effects of composite resins on cultured human gingival fibroblasts 82
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. 81
A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. 81
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 81
DIFFERENTIAL CEREBRO SPINAL FLUID PROTEOME INVESTIGATION OF LEBER HEREDITARY OPTIC NEUROPATHY (LHON) AND MULTIPLE SCLEROSIS. 80
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 77
Monospecific high-affinity and complement activating anti-GM1 antibodies are determinants in experimental axonal neuropathy 77
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 77
Repetitive Fragmentation Products of Albumin and {alpha}1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome. 76
Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations. 76
Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects. 76
Breast cancer in the era of integrating "Omics" approaches 76
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 75
High-resolution 2-DE for resolving proteins, protein adducts and complexes in plasma. 75
Improving protein identification from linear MALDI-TOF spectra: validation of an automated tool for signal denoising and peak identification 74
Flow Cytometry Analysis of Circulating Extracellular Vesicle Subtypes from Fresh Peripheral Blood Samples 74
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 73
Targeted metabolomics detects a putatively diagnostic signature in plasma and dried blood spots from head and neck paraganglioma patients 72
Proteomic analysis of protein adsorption onto haemodialysis membranes 72
Proteins and protein fragments in nephrotic syndrome: Clusters, specificity and mechanisms 71
Validation of the GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit Using Dried Blood Samples for High-Throughput Serosurveillance and Standardized Quantitative Measurement of Anti-Spike S1 IgG Antibody Responses Post-Vaccination 69
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 68
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 68
Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions 68
Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism 66
Sera mass spectrometry investigation in multiple sclerosis-affected patients 66
Ozone effect on the inflammatory and proteomic profile of human macrophages and airway epithelial cells 65
Biomarker investigations in neurodegenerative diseases 65
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 65
Analytical Evaluation of the Ideal Strategy for High-Throughput Flow Injection Analysis by Tandem Mass Spectrometry in Routine Newborn Screening 62
Multi-omics staging of locally advanced rectal cancer predicts treatment response: a pilot study 60
null 60
In vitro and in vivo lipidomics as a tool for probiotics evaluation 59
Fast LC–MS/MS screening method for the evaluation of drugs, illicit drugs, and other compounds in biological matrices 59
Tear proteomics reveals the molecular basis of the efficacy of human recombinant nerve growth factor treatment for Neurotrophic Keratopathy 58
Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials 57
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signaling pathway in diabetic cardiomyopathy 53
Proteomic Investigation of the Role of Nucleostemin in Nucleophosmin-Mutated OCI-AML 3 Cell Line 52
Extracellular Vesicles in Regenerative Processes Associated with Muscle Injury Recovery of Professional Athletes Undergoing Sub Maximal Strength Rehabilitation 52
Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis 51
Impact of Maternal Lifestyle and Dietary Habits during Pregnancy on Newborn Metabolic Profile 51
Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells 51
Totale 8.939
Categoria #
all - tutte 41.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020154 0 0 0 0 0 0 0 0 0 0 119 35
2020/2021717 86 14 97 28 53 127 24 15 109 69 40 55
2021/2022538 6 12 11 88 29 21 12 34 83 30 58 154
2022/20231.874 136 268 117 208 206 352 100 129 240 31 54 33
2023/20241.072 69 56 71 34 42 404 180 45 17 19 6 129
2024/20252.460 136 469 437 80 84 134 254 157 305 165 239 0
Totale 9.547